Goldman Sachs Group Inc Emergent Bio Solutions Inc. Call Options Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EBS
# of Institutions
160Shares Held
33.8MCall Options Held
453KPut Options Held
931K-
Black Rock Inc. New York, NY3.84MShares$32.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$28.6 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.49MShares$21 Million0.03% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA2.22MShares$18.7 Million0.0% of portfolio
-
State Street Corp Boston, MA1.91MShares$16.1 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $420M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...